Pricing Log in Create free account

NRx Pharmaceuticals, Inc. (NRXP) vs Spruce Biosciences, Inc. (SPRB)

NRx Pharmaceuticals, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. NRx Pharmaceuticals, Inc. and Spruce Biosciences, Inc. are of similar size ($119.2M and $117.3M). Spruce Biosciences, Inc. has the higher net margin (0.00% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Spruce Biosciences, Inc. leads on 9 and NRx Pharmaceuticals, Inc. on 5.

Valuation

Metric NRXP SPRB Biotechnology median
P/E n/m n/m 8.50
P/S 28.84 19.63 9.71
P/B n/m 1.15 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 22.58 1.46 9.21
Earnings yield (21.15%) (100.33%) (33.15%)
Free cash flow yield (21.12%) (44.38%) (25.50%)

Profitability

Metric NRXP SPRB Biotechnology median
Gross margin 46.64% 100.00% 65.16%
Operating margin (586.15%) 0.00% 0.00%
Net margin (691.78%) 0.00% 0.00%
Free cash flow margin (609.02%) 0.00% 0.00%
Return on equity 131.22% (105.98%) (56.36%)
Return on assets (120.41%) (82.38%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXP SPRB Biotechnology median
Revenue growth (TTM) — (51.32%) 6.02%
EPS growth (last fiscal year) 43.22% 47.59% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXP SPRB Biotechnology median
Debt to equity (2.42) 0.08 0.00
Current ratio 0.86 9.23 4.72
Net debt to EBITDA 0.48 1.34 0.96

Dividend

Metric NRXP SPRB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NRXP SPRB Biotechnology median
Market cap 117.34m 119.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack